advertising_left.gif     advertising_right.gif
 
"The Pink Sheet" 
"The Gray Sheet" 
"The Tan Sheet" 
   
HomeSubscribeAdvertisingPast IssuesStaff My AccountHelpContact
Order Reprint
search within:
 


 November 19, 2008 Volume 20, Number 225 

Daily Content from Elsevier Global Medical News
Anticancer Drug Bevacizumab May Raise Risk of Venous Thromboembolism
The antineoplastic agent bevacizumab appears to raise the risk of venous thromboembolism in patients taking concurrent chemotherapy or cytokine treatment, according to the results of a large meta-analysis.   READ MORE>>



Daily News from "The Gray Sheet"
Medtronic InFuse Sales Flat In Q2; Firm’s Spine Business Still Struggling
Medtronic is exploring alternative distribution channels in oral maxillofacial and trauma markets to grow its struggling InFuse franchise, the firm said during its Nov. 18 fiscal second quarter earnings call.   READ MORE>>


News from "The Pink Sheet" DAILY
Health Plans Readying For Comparative Effectiveness Push Next Year
With a new administration and Congress set to take the helm in Washington in January and to renew debate on health care reform, insurers are looking forward to seeing comparative effectiveness at the forefront of that debate.   READ MORE>>



Daily news from "The Tan Sheet"
Cold-fX Trial In Cancer Patients Could Put Botanical On Road To Drug Status
CV Technologies would consider submitting a new drug application for its American ginseng extract following a National Cancer Institute-sponsored phase III trial on the effects of the ingredient on acute respiratory infection in leukemia patients.   READ MORE>>


HomeSubscribeAdvertisingPast IssuesStaff My AccountHelpContact

  FDC Reports is the publisher of "The Pink Sheet"; "The Pink Sheet" DAILY; "The Gray Sheet"; FDAAdvisoryCommittee.com; "The Tan Sheet"; "The Rose Sheet"; Pharmaceutical Approvals Monthly; "The Gold Sheet"; "The Silver Sheet"; Health News Daily; PharmAsia News, an Elsevier company.